If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 493.50
Bid: 490.00
Ask: 493.50
Change: -1.50 (-0.30%)
Spread: 3.50 (0.714%)
Open: 495.00
High: 495.00
Low: 490.00
Prev. Close: 495.00
HGT Live PriceLast checked at -
HgCapital is an Investment Trust

To provide shareholders with long-term capital appreciation in excess of the FTSE All Share Index by investing in unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on HG Capital Trust (HGT)

4 Aug 2023 07:15

RNS Number : 2073I
HgCapital Trust PLC
04 August 2023
 

London, UK, 4 August 2023

 

Edison issues review on HG Capital Trust (HGT)

HgCapital Trust (HGT) continues to operate against the backdrop of a tougher macroeconomic environment, muted M&A markets and higher interest rates. Nevertheless, it delivered a 12-month NAV TR to end-March 2023 of 10.3%, which supports its longer-term outperformance of listed PE peers and major public indices. While Hg (its investment manager) expects some pressure on sales to new customers across HGT's portfolio, it sees several other organic growth drivers, including cross- and up-sell. Last 12 month (LTM) revenue and EBITDA growth to end-March 2023 remained high across its top 20 holdings at 30% and 27%, respectively.

 

Despite the tougher external environment, SaaS companies are expected to continue generating healthy top-line growth and increasing profitability over the next two years, with current Refinitiv consensus implying revenue and EBITDA growth at c 10-15% pa. HGT is a quality play in the sector, underpinned by the defensive growth profile of its holdings, Hg's sector expertise, in-house value creation team and buy-and-build strategy. HGT has historically delivered revenue and EBITDA growth of 20-30% pa at a margin above 25% (FY22: 29%) across its top 20 holdings. Therefore, it fulfils the 'Rule of 40', which warrants a valuation premium versus the broader private IT sector. The shares now trade at a c 17% discount to end-March 2023 NAV.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADXLBBXVLXBBK
Date   Source Headline
9th Sep 20197:00 amRNSInterim Report and Accounts
9th Sep 20197:00 amRNSHalf-year Report
5th Sep 20197:00 amRNSRegister Group joins team.blue
2nd Jul 201911:51 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights
26th Jun 20197:00 amRNSBlock Listing Application
18th Jun 201912:35 pmRNSHolding(s) in Company
17th Jun 20194:22 pmRNSHolding(s) in Company
14th Jun 20193:27 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSResult of Placing
10th Jun 20197:00 amRNSPlacing to raise up to approximately £80 million
7th Jun 20197:00 amRNSPerformance at Month End
28th May 20197:00 amRNSTotal Voting Rights after sub-division of shares
23rd May 20197:58 amRNSSub-Division of Shares
20th May 20195:07 pmRNSDirector/PDMR Shareholding - Replacement
17th May 20195:15 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSPerformance at Month End
7th May 20197:00 amRNSHg invests in Litera Microsystems
3rd May 20193:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20194:35 pmRNSResult of AGM
18th Apr 20197:00 amRNSHg purchases Cinven stake in Visma
9th Apr 20197:00 amRNSPerformance at Month End
22nd Mar 20194:55 pmRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSHg agrees the sale of Foundry
11th Mar 20197:00 amRNSAnnual Financial Report
11th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
29th Jan 20197:31 amRNSHg completes refinancing of A-Plan
29th Jan 20197:30 amRNSHg invests in Transporeon Group
22nd Jan 20192:14 pmRNSHolding(s) in Company
22nd Jan 20199:40 amRNSVisma welcomes CPPIB as new investor
21st Dec 20182:00 pmRNSHg invests in Combell Group
19th Dec 20185:01 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSPerformance at Month End
9th Nov 20189:28 amRNSHg agrees the sale of Atlas to Mintra Group
9th Nov 20187:00 amRNSPerformance at Month End
5th Nov 20185:11 pmRNSDirector/PDMR Shareholding
30th Oct 201812:19 pmRNSDirector/PDMR Shareholding - Replacement
30th Oct 201811:36 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSPerformance at Month End
1st Oct 20188:30 amRNSSale of Lumesse
10th Sep 20184:04 pmRNSDirector/PDMR Shareholding
10th Sep 20187:10 amRNSHg announces an investment in BrightPay
10th Sep 20187:00 amRNSHalf-year Report
10th Sep 20187:00 amRNSInterim Results - Six Months Ended 30 June 2018
30th Aug 20187:00 amRNSHg investment into Allocate Software from Hg8 Fund
20th Aug 201811:26 amRNSSyneos Health Acquires Kinapse
15th Jun 20187:00 amRNSPerformance at Month End
14th Jun 20187:30 amRNSHg invests in IT Relation
6th Jun 20188:00 amRNSHg agrees sale of Intelliflo to Invesco
29th May 20187:00 amRNSVisma Group intends to acquire Raet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.